UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry

Arthritis care & research (2010), 2015-11, Vol.67 (11), p.1529-1535

2015

Volltextzugriff (PDF)

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort

Arthritis research & therapy, 2018-12, Vol.20 (1), p.276-276, Article 276

2018

Volltextzugriff (PDF)

Outcome of adult patients with JIA treated with the biosimilar Benepali ® : results of the biologic register JuMBO

Arthritis research & therapy, 2022-12, Vol.24 (1), p.271-271, Article 271

2022

Volltextzugriff (PDF)

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Arthritis research & therapy, 2019-05, Vol.21 (1), p.125-125, Article 125

2019

Volltextzugriff (PDF)

Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry

Arthritis care & research (2010), 2017-04, Vol.69 (4), p.552-560

2017

Volltextzugriff (PDF)

S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2

Journal der Deutschen Dermatologischen Gesellschaft, 2019-09, Vol.17 (9), p.959-973

2019

Volltextzugriff (PDF)

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Journal of clinical immunology, 2022-04, Vol.42 (3), p.500-511

2022

Volltextzugriff (PDF)

Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls

Journal of rheumatology, 2015-12, Vol.42 (12), p.2419-2426

2015

Volltextzugriff (PDF)

Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort

Pediatric rheumatology online journal, 2024-10, Vol.22 (1), p.93-12, Article 93

2024

Volltextzugriff (PDF)

Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey

Journal of rheumatology, 2007-05, Vol.34 (5), p.1146

2007

Volltextzugriff (PDF)

Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study

Pediatric rheumatology online journal, 2024-03, Vol.22 (1), p.39-39, Article 39

2024

Volltextzugriff (PDF)

Fluorescence optical imaging and musculoskeletal ultrasonography in juvenile idiopathic polyarticular disease before and during antirheumatic treatment - a multicenter non-interventional diagnostic evaluation

Arthritis research & therapy, 2017-06, Vol.19 (1), p.147-147, Article 147

2017

Volltextzugriff (PDF)

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis - data from a German Inception cohort

Pediatric rheumatology online journal, 2023-04, Vol.21 (1), p.31-31, Article 31

2023

Volltextzugriff (PDF)

Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score

Rheumatology (Oxford, England), 2014-07, Vol.53 (7), p.1229-1234

2014

Volltextzugriff (PDF)

S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 1

Journal der Deutschen Dermatologischen Gesellschaft, 2019-08, Vol.17 (8), p.856-870

2019

Volltextzugriff (PDF)

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities

Pediatric rheumatology online journal, 2017-04, Vol.15 (1), p.31-31, Article 31

2017

Volltextzugriff (PDF)

Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis

Rheumatology international, 2023-08, Vol.43 (8), p.1497-1505

2023

Volltextzugriff (PDF)

Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis

Journal of rheumatology, 2005-09, Vol.32 (9), p.1832

2005

Volltextzugriff (PDF)

Course of the COVID-19 pandemic in pediatric rheumatological patients in Germany during the first 3 years (2020-2022)

Zeitschrift für Rheumatologie, 2024-09, Vol.83 (7), p.528

2024

Volltextzugriff (PDF)

Spondyloarthritis in childhood and adulthood

Zeitschrift für Rheumatologie, 2022-02, Vol.81 (1), p.14

2022

Volltextzugriff (PDF)

Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis

Rheumatology (Oxford, England), 2014-07, Vol.53 (7), p.1245-1249

2014

Volltextzugriff (PDF)

Musculoskeletal manifestations and rheumatic symptoms in patients with cystic fibrosis (CF) no observations of CF-specific arthropathy

Journal of rheumatology, 2008-09, Vol.35 (9), p.1882

2008

Volltextzugriff (PDF)

Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry

Arthritis & rheumatology (Hoboken, N.J.), 2014-09, Vol.66 (9), p.2580-2589

2014

Volltextzugriff (PDF)

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

Annals of the rheumatic diseases, 2016-05, Vol.75 (5), p.855-861

2016

Volltextzugriff (PDF)

Identification of an Amino Acid Motif in HLA–DRβ1 That Distinguishes Uveitis in Patients With Juvenile Idiopathic Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2018-07, Vol.70 (7), p.1155-1165

2018

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(85)

Sprache

Englisch
(83)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(85)
Life Sciences & Biomedicine
(82)
Science & Technology
(82)
Child
(80)
Rheumatology
(71)
Female
(67)
Male
(67)
Arthritis, Juvenile - Drug Therapy
(54)
Child, Preschool
(47)
Antirheumatic Agents - Therapeutic Use
(36)
Treatment Outcome
(35)
Juvenile Idiopathic Arthritis
(31)
Arthritis
(28)
Pediatrics
(25)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Registries
(21)
Arthritis, Juvenile - Diagnosis
(20)
Severity Of Illness Index
(18)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry

Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohort

Outcome of adult patients with JIA treated with the biosimilar Benepali ® : results of the biologic register JuMBO

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial

Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry

S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls

Physical (in)activity and screen-based media use of adolescents with juvenile idiopathic arthritis over time - data from a German inception cohort

Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey

Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study

Fluorescence optical imaging and musculoskeletal ultrasonography in juvenile idiopathic polyarticular disease before and during antirheumatic treatment - a multicenter non-interventional diagnostic evaluation

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis - data from a German Inception cohort

Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity score

S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 1

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities

Prevalence and risk factors of depressive symptoms in children and adolescents with juvenile idiopathic arthritis

Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis

Course of the COVID-19 pandemic in pediatric rheumatological patients in Germany during the first 3 years (2020-2022)

Spondyloarthritis in childhood and adulthood

Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis

Musculoskeletal manifestations and rheumatic symptoms in patients with cystic fibrosis (CF) no observations of CF-specific arthropathy

Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry

Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)

Identification of an Amino Acid Motif in HLA–DRβ1 That Distinguishes Uveitis in Patients With Juvenile Idiopathic Arthritis

Aktive Filter

Suchergebnisse filtern